Debt-to-equity of Atea Pharmaceuticals, Inc. from 30 Jun 2021 to 31 Dec 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Atea Pharmaceuticals, Inc. quarterly Debt-to-equity in % history and change rate from 30 Jun 2021 to 31 Dec 2025.
  • Atea Pharmaceuticals, Inc. Debt-to-equity for the quarter ending 31 Dec 2025 was 9%, a 20% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

Atea Pharmaceuticals, Inc. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q4 2025 9% +1.5% +20% 31 Dec 2025
Q3 2025 7.1% -0.63% -8.2% 30 Sep 2025
Q2 2025 6.8% -0.19% -2.7% 30 Jun 2025
Q1 2025 6.8% +0.61% +9.9% 31 Mar 2025
Q4 2024 7.5% +2.8% +61% 31 Dec 2024
Q3 2024 7.8% +3.8% +97% 30 Sep 2024
Q2 2024 7% +3.3% +90% 30 Jun 2024
Q1 2024 6.2% +2.2% +54% 31 Mar 2024
Q4 2023 4.7% +0.09% +2% 31 Dec 2023
Q3 2023 3.9% -1.9% -32% 30 Sep 2023
Q2 2023 3.7% -11% -75% 30 Jun 2023
Q1 2023 4% -21% -84% 31 Mar 2023
Q4 2022 4.6% -30% -87% 31 Dec 2022
Q3 2022 5.8% -42% -88% 30 Sep 2022
Q2 2022 15% -37% -71% 30 Jun 2022
Q1 2022 25% 31 Mar 2022
Q4 2021 34% 31 Dec 2021
Q3 2021 48% 30 Sep 2021
Q2 2021 52% 30 Jun 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.